Analyst Research: Rexahn Pharmaceuticals Inc (RNN)

RNN on American Stock Exchange

0.35USD
21 May 2013
Price Change (% chg)

$0.04 (+12.83%)
Prev Close
$0.31
Open
$0.33
Day's High
$0.35
Day's Low
$0.31
Volume
1,651,549
Avg. Vol
377,061
52-wk High
$0.81
52-wk Low
$0.28

Search Stocks
Reports per page
Select Report Title Date Provider Pgs Price
Thomson Reuters Stock Report - REXAHN PHARMACEUTICALS INC. (RNN-A) 21 May 2013 Thomson Reuters Stock Report 11 25.00
REXAHN PHARMACEUTICALS INC (RNN) 12-months forecast 17 May 2013 Pechala's Reports 1 15.00
Rexahn Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 17 May 2013 Reuters Investment Profile 12 20.00
Rexahn Pharmaceuticals, Inc. (RNN) - Financial Analysis Review 21 Apr 2013 GlobalData 32 125.00
 

People

Name Age Since Current Position

Chang Ahn

 60 2013 Chairman of the Board, Chief Scientist

Rakesh Soni

 56 2009 President, Chief Operating Officer

Peter Suzdak

 2013 Chief Executive Officer

Tae Heum Jeong

 41 2012 Chief Financial Officer, Secretary

Charles Beever

 59 2006 Independent Director
» More People

Rexahn Pharmaceuticals Inc News

» More RNN News
Search Stocks